NCT04969419View on ClinicalTrials.gov

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo

CompletedOBSERVATIONAL
Enrollment

75,771

Participants

Timeline

Start Date

June 18, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

April 4, 2023

Conditions
VitiligoMelanoma (Skin)Nonmelanoma Skin CancerSquamous Cell CarcinomaBasal Cell CarcinomaActinic Keratoses
Interventions
OTHER

Exposure of skin cancer of interest

Melanoma and nonmelanoma skin cancers: squamous cell carcinoma, basal cell carcinoma and actinic keratoses.

Trial Locations (1)

WC1X 8QT

Momentum Data Ltd, London

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Momentum Data

INDUSTRY

NCT04969419 - Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo | Biotech Hunter | Biotech Hunter